Home/Pipeline/Bridge Capture™ for Liquid Biopsy

Bridge Capture™ for Liquid Biopsy

Oncology (e.g., Colorectal Cancer) - ctDNA detection & MRD monitoring

ValidationActive

Key Facts

Indication
Oncology (e.g., Colorectal Cancer) - ctDNA detection & MRD monitoring
Phase
Validation
Status
Active
Company

About Genomill Health

Genomill Health is a private, pre-revenue diagnostics company developing a streamlined NGS technology platform. Its core innovations, the Geno1® library prep system with Bridge Capture™ and Nicking Loop™, aim to significantly reduce the complexity, time, and cost of sensitive genomic testing, with a focus on liquid biopsy and minimal residual disease monitoring in cancer. The company is generating early validation data and media recognition, positioning its technology for future clinical adoption and commercialization.

View full company profile

Therapeutic Areas